The proteins CTSS and GSTO1 could accurately distinguish people with primary Sjögren’s syndrome from unaffected individuals, a study suggests, meaning they show promise as diagnostic biomarkers and possible therapeutic targets for Sjögren’s. “These insights may lead to the development of targeted therapies and improved management strategies for individuals living…
News
Lip salivary gland biopsy may not be predictive of a Sjögren’s syndrome diagnosis, particularly when it’s based on tissue samples classified as showing a low level of inflammation and damage, according to a study. In 16% of the cases assessed in the study, different pathology teams would draw different conclusions…
Kiniksa Pharmaceuticals has launched a Phase 2b clinical trial to test its injectable therapy abiprubart against a placebo in people with Sjögren’s syndrome. The trial, mainly designed to assess the treatment’s effects on disease severity, is expected to involve about 201 Sjögren’s patients. Kiniksa reports that the trial…
World Sjögren’s Day is held every July 23, the birthday of Henrik Sjögren, the Swedish ophthalmologist who first identified Sjögren’s syndrome in 1933, and this year, to observe the 40th anniversary of the Sjögren’s Foundation, Amgen has pledged a dollar-to-dollar match up to $40,000, meaning donations supporting…
A new photo-detection method was able to accurately and quantitatively measure lactoferrin levels in the tears of people with dry eye disease (DED) associated with Sjögren’s syndrome or other conditions, a study shows. The method also let researchers distinguish patients with DED caused by Sjögren’s from other DED…
The oral microbiome — the community of bacteria living in the mouth — of people with primary Sjögren’s syndrome (pSS) includes a large number of bacteria linked to inflammation and dental caries, or cavities, as well as bacteria that facilitate the colonization of the oral mucosa by other disease-causing…
Introducing immunosuppressive or biological therapies early in people with Sjögren’s syndrome may prevent its progression to a bodywide systemic condition, a study in France suggests. “In our study, we can see that the introduction of [immunosuppressive agents] or biotherapy in systemic forms is only effective in around 50% of…
Older age, smoking, and a condition called Raynaud’s phenomenon are risk factors for developing interstitial lung disease (ILD) among people with primary Sjögren’s syndrome, according to a recent study. The study, “Interstitial lung disease and associated factors in patients with Sjögren’s syndrome,” was published in the…
To help shed light on what it’s like to live with Sjögren’s syndrome, a systemic autoimmune condition thought to affect about 4 million U.S. residents, this year’s Sjogren’s Awareness Month will focus on stories from the patients themselves. The annual April event is designed to showcase the disorder and…
Patients with primary Sjögren’s syndrome who have extra-glandular symptoms have higher levels of the chemokine CXCL9 than those only affected in the saliva and tear-producing glands, a study finds. CXCL9 is a small signaling molecule involved in the migration and maturation of lymphocytes, a type of immune cell thought…
Recent Posts
- Sjögren’s symptoms extend far beyond dryness, U.S. survey finds
- Study links anti-Ro antibody patterns to disease features in Sjögren’s
- Global trial of telitacicept for Sjögren’s doses first patient ‘within weeks’
- Patients, advocates working this month to raise awareness of Sjögren’s
- Biotech, US university partner on new ways to speed Sjögren’s diagnosis
- New study links alternative splicing patterns to Sjögren’s severity
- Initial data from trial testing CLN-978 in Sjögren’s expected this year
- Sjögren’s disease may increase risk of certain digestive cancers: Korean study
- Sjögren’s patients face ‘invisible’ symptoms, lack of understanding
- Sjögren’s protein score may help measure salivary gland inflammation